Adjunctive Strategies for Benign Maxillofacial Pathology.

Area of Science:

• Oral and Maxillofacial Surgery
• Oncology
• Pathology

Background:

• Benign cysts and neoplasms in the maxillofacial region exhibit variable behavior, with some causing rapid destruction of adjacent tissues.
• Despite benign histology, these lesions frequently necessitate aggressive treatment to prevent recurrence.
• Surgical interventions for these lesions can be associated with significant morbidity.

Purpose of the Study:

• To review the current understanding of benign maxillofacial cysts and neoplasms.
• To explore the evolving landscape of treatment modalities, including less invasive options.
• To highlight the potential impact of molecular and genomic insights on future therapeutic strategies.

Main Methods:

• Literature review of benign maxillofacial cysts and neoplasms.
• Analysis of treatment outcomes and associated morbidities.
• Discussion of emerging molecular and genomic research relevant to pathogenesis.

Main Results:

• Benign maxillofacial lesions pose a significant clinical challenge due to their destructive potential and recurrence rates.
• Current treatments, primarily surgical, carry substantial morbidity.
• Advancements in understanding the molecular pathogenesis are paving the way for targeted therapies.

Conclusions:

• Further research into the molecular and genomic underpinnings of these lesions is crucial.
• Development of targeted, less invasive treatments holds promise for reducing patient morbidity.
• A shift towards precision medicine approaches may revolutionize the management of benign maxillofacial cysts and neoplasms.